Table of Content

1 Markets
1.1 Product Definition
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Scope
1.2.1 Scope of the Work
1.2.2 Key Questions Answered in the Report
1.3 Research Methodology
1.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
1.3.2 Data Sources
1.3.2.1 Primary Data Sources
1.3.2.2 Secondary Data Sources
1.3.3 Market Estimation Model

2 Cell and Gene Therapy Manufacturing QC Market: Regulatory Framework
2.1 Chemistry, Manufacturing, and Control (CMC) Requirements by the Food and Drug Administration (FDA)
2.1.1 Product Testing
2.1.2 Microbial Testing
2.1.3 Identity
2.1.4 Purity
2.1.5 Potency
2.1.6 Viability
2.1.7 Cell Number or Dose
2.2 Quality Aspects of Cell and Gene Therapy Products by the European Medicines Agency (EMA)
2.2.1 Characterization
2.2.2 Identity Testing
2.2.3 Purity Testing
2.3 Current Good Manufacturing Practice (CGMP) Regulations
2.3.1 U.S.
2.3.2 Europe
2.3.3 Asia-Pacific
2.4 Global Regulatory Framework: Cell and Gene Therapy Manufacturing QC Market

3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Market Overview
3.1 Market Overview
3.1.1 Realistic Growth Scenario
3.1.2 Optimistic Scenario
3.1.3 Pessimistic Scenario
3.2 Market Footprint and Growth Potential
3.3 Future Potential
3.4 COVID-19 Impact on Market
3.4.1 Impact on Research and Clinical Operations
3.4.2 COVID-19 Impact: Current Scenario of the Market
3.4.3 Pre- and Post-COVID-19 Impact Assessment
3.4.3.1 Pre-COVID-19 Phase
3.4.3.2 Post-COVID-19 Phase
3.5 Market Dynamics
3.6 Market Sizing and Forecast
3.6.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
3.6.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
3.6.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
3.6.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
3.6.5 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)

4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: by Country
4.1 Singapore
4.1.1 Singapore Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.1.2 Singapore Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.1.3 Singapore Cell and Gene Therapy Manufacturing QC Market (by Process)
4.1.4 Singapore Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.1.5 Singapore Cell and Gene Therapy Manufacturing QC Market (by Application)
4.2 Japan
4.2.1 Japan Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.2.2 Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.2.3 Japan Cell and Gene Therapy Manufacturing QC Market (by Process)
4.2.4 Japan Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.2.5 Japan Cell and Gene Therapy Manufacturing QC Market (by Application)
4.3 South Korea
4.3.1 South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.3.2 South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.3.3 South Korea Cell and Gene Therapy Manufacturing QC Market (by Process)
4.3.4 South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.3.5 South Korea Cell and Gene Therapy Manufacturing QC Market (by Application)
4.4 Australia
4.4.1 Australia Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.4.2 Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.4.3 Australia Cell and Gene Therapy Manufacturing QC Market (by Process)
4.4.4 Australia Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.4.5 Australia Cell and Gene Therapy Manufacturing QC Market (by Application)
4.5 India
4.5.1 India Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.5.2 India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.5.3 India Cell and Gene Therapy Manufacturing QC Market (by Process)
4.5.4 India Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.5.5 India Cell and Gene Therapy Manufacturing QC Market (by Application)
4.6 Thailand
4.6.1 Thailand Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.6.2 Thailand Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.6.3 Thailand Cell and Gene Therapy Manufacturing QC Market (by Process)
4.6.4 Thailand Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.6.5 Thailand Cell and Gene Therapy Manufacturing QC Market (by Application)
4.7 Malaysia
4.7.1 Malaysia Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.7.2 Malaysia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.7.3 Malaysia Cell and Gene Therapy Manufacturing QC Market (by Process)
4.7.4 Malaysia Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.7.5 Malaysia Cell and Gene Therapy Manufacturing QC Market (by Application)
4.8 Indonesia
4.8.1 Indonesia Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.8.2 Indonesia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.8.3 Indonesia Cell and Gene Therapy Manufacturing QC Market (by Process)
4.8.4 Indonesia Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.8.5 Indonesia Cell and Gene Therapy Manufacturing QC Market (by Application)
4.9 Rest-of-Asia-Pacific
4.9.1 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering)
4.9.2 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type)
4.9.3 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process)
4.9.4 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology)
4.9.5 Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application)

5 Company Profiles
5.1 Bio-Techne Corporation
5.1.1 Company Overview
5.1.2 Role of Bio-Techne Corporation in the Cell and Gene Therapy Manufacturing QC Market
5.1.3 Product Portfolio
5.1.4 Key Competitors
5.1.5 Financials
5.1.6 Analyst Perspective
5.2 Danaher Corporation (Cytiva)
5.2.1 Company Overview
5.2.2 Role of Danaher Corporation (Cytiva) in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.2.3 Product Portfolio
5.2.4 Key Competitors
5.2.5 Financials
5.2.6 Analyst Perspective
5.3 F. Hoffmann-La Roche Ltd
5.3.1 Company Overview
5.3.2 Role of F. Hoffmann-La Roche Ltd in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.3.3 Product Portfolio
5.3.4 Key Competitors
5.3.5 Financials
5.3.6 Analyst Perspective
5.4 Lonza
5.4.1 Company Overview
5.4.2 Role of Lonza in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.4.3 Product Portfolio
5.4.4 Key Competitors
5.4.5 Financials
5.4.6 Analyst Perspective
5.5 Miltenyi Biotec B.V. & Co. KG
5.5.1 Company Overview
5.5.2 Role of Miltenyi Biotec B.V. & Co. KG in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.5.3 Product Portfolio
5.5.4 Key Competitors
5.5.5 Analyst Perspective
5.6 Sartorius AG
5.6.1 Company Overview
5.6.2 Role of Sartorius AG in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.6.3 Product Portfolio
5.6.4 Key Competitors
5.6.5 Financials
5.6.6 Analyst Perspective
5.7 Thermo Fisher Scientific Inc.
5.7.1 Company Overview
5.7.2 Role of Thermo Fisher Scientific Inc. in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.7.3 Product Portfolio
5.7.4 Key Competitors
5.7.5 Financials
5.7.6 Analyst Perspective
5.8 WuXi AppTec
5.8.1 Company Overview
5.8.2 Role of WuXi AppTec in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.8.3 Product Portfolio
5.8.4 Key Competitors
5.8.5 Financials
5.8.6 Analyst Perspective
5.9 Fujifilm Holdings Corporation
5.9.1 Company Overview
5.9.2 Role of Fujifilm Holdings Corporation in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.9.3 Product Portfolio
5.9.4 Key Competitors
5.9.5 Financials
5.9.6 Analyst Perspective
5.10 Merck KGaA
5.10.1 Company Overview
5.10.2 Role of Merck KGaA in the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market
5.10.3 Product Portfolio
5.10.4 Key Competitors
5.10.5 Financials
5.10.6 Analyst Perspective

List of Tables
Table 1: Summary of Regulatory Requirements in Asia-Pacific
Table 2: Key Questions Answered in the Report
Table 3: Global Regulatory Scenario: Cell and Gene Therapy Manufacturing QC Market
Table 4: List of Approved CGT Drugs in Asian Countries
Table 5: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Dynamics, Impact Analysis
Table 6: Some of the Approved Cell and Gene Therapies in Japan

List of Figures
Figure 1: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 2: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, Impact Analysis
Figure 3: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), % Share, 2023 and 2033
Figure 4: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), % Share, 2023 and 2033
Figure 5: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), % Share, 2023 and 2033
Figure 6: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), % Share, 2023 and 2033
Figure 7: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), % Share, 2023 and 2033
Figure 8: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Segmentation
Figure 9: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Research Methodology
Figure 10: Primary Research Methodology
Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
Figure 12: Top-Down Approach (Segment-Wise Analysis)
Figure 13: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Realistic Scenario), $Million, 2023-2033
Figure 14: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Optimistic Scenario), $Million, 2023-2033
Figure 15: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Growth Potential (Pessimistic Scenario), $Million, 2023-2033
Figure 16: Impact of COVID-19 on CGT Developmental Activities
Figure 17: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 18: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 19: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 20: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 21: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 22: Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 23: Singapore Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 24: Singapore Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 25: Singapore Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 26: Singapore Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 27: Singapore Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 28: Singapore Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 29: Japan Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 30: Japan Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 31: Japan Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 32: Japan Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 33: Japan Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 34: Japan Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 35: South Korea Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 36: South Korea Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 37: South Korea Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 38: South Korea Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 39: South Korea Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 40: South Korea Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 41: Australia Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 42: Australia Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 43: Australia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 44: Australia Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 45: Australia Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 46: Australia Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 47: India Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 48: India Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 49: India Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 50: India Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 51: India Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 52: India Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 53: Thailand Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 54: Thailand Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 55: Thailand Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 56: Thailand Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 57: Thailand Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 58: Thailand Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 59: Malaysia Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 60: Malaysia Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 61: Malaysia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 62: Malaysia Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 63: Malaysia Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 64: Malaysia Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 65: Indonesia Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 66: Indonesia Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 67: Indonesia Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 68: Indonesia Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033u
Figure 69: Indonesia Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 70: Indonesia Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 71: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market, $Million, 2023-2033
Figure 72: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Offering), $Million, 2023-2033
Figure 73: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Therapy Type), $Million, 2023-2033
Figure 74: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process), $Million, 2023-2033
Figure 75: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Technology), $Million, 2023-2033
Figure 76: Rest-of-Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Application), $Million, 2023-2033
Figure 77: Bio-Techne Corporation: Overall Financials, $Million, 2021-2023
Figure 78: Danaher Corporation (Cytiva): Overall Financials, $Million, 2021-2023
Figure 79: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2021-2023
Figure 80: Lonza: Overall Financials, $Million, 2021-2023
Figure 81: Sartorius AG: Overall Financials, $Million, 2021-2023
Figure 82: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2021-2023
Figure 83: WuXi AppTec: Overall Financials, $Million, 2021-2023
Figure 84: Fujifilm Holdings Corporation: Overall Financials, $Million, 2021-2023
Figure 85: Merck KGaA: Overall Financials, $Million, 2021-2023